Skip to main content
. 2024 Dec 19;25:1033. doi: 10.1186/s12891-024-08080-y

Table 1.

Patient demographics data between patients with and without tranexamic acid

Total (n = 8042) TXA (n = 3664) no TXA (n = 4378) p-value
Age, year (mean ± SD) 67.9 ± 10.3 67.7 ± 10.6 68.1 ± 10.0 0.241
Male (n, %) 2236 (27.8) 1047 (28.6) 1189 (27.2) 0.158
BMI, kg/m2 (mean ± SD) 26.9 ± 4.3 26.9 ± 4.5 26.9 ± 4.1 0.229
Preoperative Hb, g/dL (mean ± SD) 12.5 ± 1.7 12.2 ± 1.8 12.7 ± 1.6 0.000
Surgical time, min (mean ± SD) 148 ± 31 142 ± 30 154 ± 31 0.000
Joint (n. %) < 0.001
 Hip 1766 (22.0) 967 (26.5) 796 (18.2)
 Knee 6276 (78.0) 2697 (73.5) 3582 (81.8)
Diagnosis 0.478
 Osteoarthritis 6894 (85.7) 3086 (84.3) 3808 (87.0)
 Osteonecrosis 699 (8.7) 358 (9.8) 341 (7.8)
 Rheumatoid arthritis 195 (2.4) 116 (3.2) 79 (1.8)
 Ankylosing spondylitis 24 (0.3) 10 (0.3) 14 (0.3)
 Posttraumatic osteoarthritis 153 (1.9) 71 (1.9) 82 (1.9)
 Hip dysplasia 70 (0.9) 18 (0.5) 52 (1.2)
 Gouty arthritis 5 (0.1) 3 (0.1) 2 (0.0)
Lateral (n, %) 0.834
 Right 4198 (52.2) 1913 (52.2) 2285 (52.2)
 Left 3837 (47.7) 1749 (47.7) 2088 (47.7)
 Bilateral 6 (0.1) 2 (0.1) 4 (0.1)
CCI > 2 (n, %) 5222 (64.9) 2258 (61.7) 2964 (67.7) < 0.001
Comorbidities (n, %)
 Heart disease 368 (4.6) 165 (4.5) 203 (4.6) 0.775
 COPD 192 (2.4) 100 (2.7) 92 (2.1) 0.066
 Diabetes 1738 (21.6) 760 (20.7) 978 (22.3) 0.083
 Renal failure 1629 (20.3) 430 (11.8) 1199 (27.4) < 0.001
 Liver disease 164 (2.0) 57 (1.6) 107 (2.4) 0.005
 Rheumatoid Arthritis 266 (3.3) 97 (2.6) 169 (3.9) 0.002
ASA (n, %) < 0.001a
 1 146 (1.8) 42 (1.1) 105 (2.4)
 2 4810 (59.8) 2146 (58.6) 2664 (60.8)
 3 3085 (38.4) 1476 (40.3) 1609 (36.8)
 4 1 (0) 1 (0) 0 (0)
Anesthesia (n, %) < 0.001a
 General 7253 (90.2) 3227 (88.1) 4026 (92.0)
 Regional 789 (9.8) 437 (11.9) 352 (8.0)

a fisher’s exact test

TXA, tranexamic acid; BMI, body mass index; Hb, hemoglobin; TKA, total knee arthroplasty; CCI, Charlson Comorbidity Index; ASA, American Society of Anesthesiology; COPD, chronic obstructive pulmonary disease; IQR, interquartile range